miR-1260b, mediated by YY1, activates KIT signaling by targeting SOCS6 to regulate cell proliferation and apoptosis in NSCLC
2019 · Cell Death and Disease · 67 citations
https://doi.org/10.1038/s41419-019-1390-y
J
Jing Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
262
Papers
7.5K
Citations
45
h-index
144
i10-index
Jing Xu is an academic researcher from Fujian Medical University. The author has contributed to research in topics: MicroRNA in disease regulation & Cancer-related molecular mechanisms research & Circular RNAs in diseases. The author has an h-index of 45, co-authored 223 publications.
ORCID: 0000-0002-8050-6831Papers by this author
worksSystematic cancer-testis gene expression analysis identified CDCA5 as a potential therapeutic target in esophageal squamous cell carcinoma
2019 · EBioMedicine · 61 citations
https://doi.org/10.1016/j.ebiom.2019.07.030
VEGF attenuates development from cardiac hypertrophy to heart failure after aortic stenosis through mitochondrial mediated apoptosis and cardiomyocyte proliferation
2011 · Journal of Cardiothoracic Surgery · 50 citations
https://doi.org/10.1186/1749-8090-6-54
miR-30c regulates proliferation, apoptosis and differentiation via the Shh signaling pathway in P19 cells
2016 · Experimental & Molecular Medicine · 47 citations
https://doi.org/10.1038/emm.2016.57
Progress and application of circulating tumor cells in non-small cell lung cancer
2021 · Molecular Therapy — Oncolytics · 29 citations
https://doi.org/10.1016/j.omto.2021.05.005
A systematic analysis of predicted MiR-31-targets identifies a diagnostic and prognostic signature for lung cancer
2014 · Biomedicine & Pharmacotherapy · 26 citations
https://doi.org/10.1016/j.biopha.2014.03.009
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat